Jaslok Hospital launches heart transplant programme in Mumbai
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
It is estimated that one-third of our country’s population has some form of these disorders
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
Cryoballoon catheter ablation, a minimally invasive procedure, is one of the therapeutic modalities to manage Atrial fibrillation
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
The transaction is anticipated to close in the first quarter of 2022
Cipla is a leading global pharma company
Cobas pure provides clinical labs with access to more than 230 diagnostic tests across a wide range of disease areas including infectious diseases, oncology and cardiology
One of the key factors driving the market growth is the rise in the occurrence of chronic cardiovascular diseases such as heart failure and coronary artery disease: Valuates Reports
The designation is based on results from the EMPEROR-Preserved phase III trial, which established Jardiance as the first therapy to show statistically significant improvement in heart failure outcomes in adults with heart failure with a preserved ejection fraction
Subscribe To Our Newsletter & Stay Updated